These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21806477)

  • 21. Targeting the epidermal growth factor receptor a new strategy in cancer treatment.
    Gianni L; Grasselli G
    Suppl Tumori; 2002; 1(4):S60-1. PubMed ID: 12415824
    [No Abstract]   [Full Text] [Related]  

  • 22. Cetuximab: potential role as first-line treatment for advanced non-small cell lung cancer.
    Pirker R
    Clin Adv Hematol Oncol; 2008 Oct; 6(10):735-6. PubMed ID: 18997663
    [No Abstract]   [Full Text] [Related]  

  • 23. Will FLEX allow us flexibility in the therapy of advanced non-small-cell lung cancer? Insights from the 2008 American Society of Clinical Oncology Meeting.
    Langer CJ
    Clin Lung Cancer; 2008 Sep; 9(5):249-51. PubMed ID: 18824445
    [No Abstract]   [Full Text] [Related]  

  • 24. CIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancer.
    Crombet Ramos T; Rodríguez PC; Neninger Vinageras E; Garcia Verdecia B; Lage Davila A
    Expert Rev Vaccines; 2015; 14(10):1303-11. PubMed ID: 26295963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Necitumumab, a fully human IgG1 mAb directed against the EGFR for the potential treatment of cancer.
    Dienstmann R; Tabernero J
    Curr Opin Investig Drugs; 2010 Dec; 11(12):1434-41. PubMed ID: 21154125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Necitumumab for the treatment of squamous cell non-small cell lung cancer.
    Brinkmeyer JK; Moore DC
    J Oncol Pharm Pract; 2018 Jan; 24(1):37-41. PubMed ID: 27913776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How do U.S. medical oncologists learn and apply new clinical trials information from press releases in nonmedical media? A case study based on ECOG 4599.
    Dornbusch D; Allegra C; Willey J; Andrews M; Leff R; Epstein J; Jones J; Lokey L; Green MR
    Oncologist; 2006 Jan; 11(1):31-8. PubMed ID: 16401711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can epidermal growth factor receptor-fluorescent in situ hybridization predict clinical benefit from cetuximab treatment in patients with non-small-cell lung cancer?
    Takano T; Ota S; Hori A; Seki N; Eguchi K
    J Clin Oncol; 2009 Jan; 27(3):464-5; author reply 465-7. PubMed ID: 19064956
    [No Abstract]   [Full Text] [Related]  

  • 29. Receptor kinase inhibitors target NSCLC: two antibodies and a small-molecule MET inhibitor.
    Yee D
    BioDrugs; 2011 Aug; 25(4):271-3. PubMed ID: 21815704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trastuzumab in the treatment of advanced non-small-cell lung cancer: is there a role?
    Kalemkerian G
    J Clin Oncol; 2005 Feb; 23(6):1325-6; author reply 1326-7. PubMed ID: 15718337
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic targeting of epidermal growth factor receptor with monoclonal antibodies.
    Siena S; Artale S; Vanzulli A; Marrapese G; Bevilacqua L; Secondino S; Sironi O; Schiavo R; Moroni M; Pedrazzoli P
    Suppl Tumori; 2002; 1(4):S46-8. PubMed ID: 12415818
    [No Abstract]   [Full Text] [Related]  

  • 32. Cetuximab in NSCLC: another trial needed.
    Perrone F
    Lancet Oncol; 2011 Jan; 12(1):3-4. PubMed ID: 21169059
    [No Abstract]   [Full Text] [Related]  

  • 33. [Not Available].
    Moro-Sibilot D; Ferrer L; Levra MG; Toffart AC
    Bull Cancer; 2016 Jun; 103(6 Suppl 1):S12-5. PubMed ID: 27494968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Research Progress of Antibody-conjugated Drugs in Non-small Cell Lung Cancer].
    Liu Y; Wei S
    Zhongguo Fei Ai Za Zhi; 2024 Jun; 27(6):431-440. PubMed ID: 39026494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted programmed cell death in lung cancer treatment.
    Zimmerman MP; Mehr SR
    Am J Manag Care; 2014 Mar; 20(5 Spec No.):E3. PubMed ID: 25618630
    [No Abstract]   [Full Text] [Related]  

  • 36. Nivolumab (Opdivo) for metastatic melanoma and metastatic NSCLC.
    Med Lett Drugs Ther; 2015 Jun; 57(1470):85-7, 94. PubMed ID: 26035747
    [No Abstract]   [Full Text] [Related]  

  • 37. [Research Progress of Antibody-drug Conjugates in Advanced Non-small Cell Lung Cancer].
    Wang N; Zhao L; Zhang D; Jia Y; Kong F
    Zhongguo Fei Ai Za Zhi; 2022 Mar; 25(3):214-218. PubMed ID: 35340165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical potential of necitumumab in non-small cell lung carcinoma.
    Genova C; Hirsch FR
    Onco Targets Ther; 2016; 9():5427-37. PubMed ID: 27621656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of talactoferrin alpha in the treatment of non-small cell lung cancer.
    Kelly RJ; Giaccone G
    Expert Opin Biol Ther; 2010 Sep; 10(9):1379-86. PubMed ID: 20684737
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.